We imagine a world where a recurring blood test helps physicians and patients monitor and sustain health over a lifetime.
FBB CEO Dr. Urnovitz built the first liquid biopsy for cancer and now he is building the first liquid biopsy for neurologic diseases
Venture fund Loyal VC invested just a few months after FBB Biomed’s founding on the back of our pre-clinical data
We are experts in pioneering novel diagnostics and getting them to market with the help of key opinion leaders
Close collaboration with the University of Iowa medical school; Graduate of the Iowa G2M Accelerator
FBB Biomed is an Iowa-based biotechnology company harnessing the latest advancements in genetic sequencing and bioinformatics to develop novel approaches in diagnosing and controlling disease through RNA.
Inventor of the first liquid biopsy, serial biotech Founder-CEO
Operations & logistics manager for diagnostics companies
B2B business development executive, AI & Big Data
© 2022 All Rights Reserved